FR941013-1-00040 FR941013-1-00005 (e) Within a reasonable period of time after receipt of the application for reinstatement of the exemption, The Administrator shall notify the applicant of his acceptance or non-acceptance of his application, and if not accepted, the reason therefor. If the application is accepted for filing, the Administrator shall issue and publish in the Federal Register his order on the reinstatement of the exemption for the particular drug product, which shall include a reference to the legal authority under which the order is based. This order shall specify the date on which it shall take effect. The Administrator shall permit any interested person to file written comments on or objections to the order. If any such comments raise significant issues regarding any finding of fact or conclusion of law upon which the order is based, the Administrator shall immediately suspend the effectiveness of the order until he may reconsider the application in light of the comments and objections filed. Thereafter, the Administrator shall reinstate, revoke, or amend his original order as he determines appropriate. (f) Unless the Administrator has evidence that the drug product is being diverted, as determined by applying the factors set forth in paragraph (a) of this section, and the Administrator so notifies the applicant, transactions involving a specific drug product will not be considered regulated transactions during the following periods: (1) While a bonafide application for reinstatement of exemption under paragraph (d) of this section for the specific drug product is pending resolution, provided that the application for reinstatement is filed not later than 60 days after the publication of the final order removing the exemption; and (2) For a period of 60 days following the Administrator's denial of an application for reinstatement. (g) An order published by the Administrator in the Federal Register pursuant to paragraph (e) of this section to reinstate an exemption may be modified or revoked with respect to a particular drug product upon a finding that: (1) Applying the factors set forth in paragraph (a) to the particular drug product, the drug product is being diverted; or (2) There is a significant change in the data that led to the issuance of the final rule. §1310.11 Reinstatement of exemption for drug products distributed under the Food, Drug and Cosmetic Act. (a) The Administrator has reinstated the exemption for the drug products listed in paragraph (e) of this section from application of sections 302, 303, 310, 1007, and 1008 of the Act (21 U.S.C. 822&hyph;823, 830, and 957&hyph;958 to the extent described in paragraphs (b), (c), and (d) of this section. (b) Records and reports: All regulated persons who manufacture an exempted drug product must keep complete and accurate records and file all reports required under §§1310.05 and 1310.06 on all listed chemicals used in manufacturing the exempt drug product. Transactions involving reinstated exempt drug products contained in paragraph (e) of this section are not regulated transactions and thus records and reports are not required to be kept for listed chemicals once they become part of the reinstated exempt drug product. (c) No reinstated exemption granted pursuant to 1310.10 affects the criminal liability for illegal possession or distribution of listed chemicals contained in the exempt drug product. (d) Changes in exempt drug product compositions: Any change in the quantitative or qualitative composition, trade name or other designation of an exempt drug product listed in paragraph (e) of this section requires a new application for reinstatement of the exemption. (e) The following drug products, in the form and quantity listed in the application submitted (indicated as the ``date'') are designated as reinstated exempt drug products for the purposes set forth in this section: Exempt Drug Products 1Supplier 1Product name 1Form 1Date [Reserved] §1310.12 Exemption of chemical mixtures; application. (a) The Administrator may, by publication of a Final Rule in the Federal Register , exempt from the application of all or any part of the Act, a chemical mixture consisting of two or more chemical substances, at least one of which is not a List I or List II chemical, if: (1) The mixture is formulated in such a way that it cannot be easily used in the illicit production of a controlled substance; and (2) The listed chemical or chemicals contained in the chemical mixture cannot be readily recovered. (b) Any person seeking an exemption for a chemical mixture from the application of all or any part of the Act, pursuant to paragraph (a) of this section, may apply to the Administrator, Drug Enforcement Administration, Department of Justice, Washington, DC 20537. (c) An application for exemption under this section shall contain the following information: (1) The name, address, and registration number, if any, of the applicant; (2) The date of the application; (3) The name, address, and registration number, if any, of the manufacturer or importer of the chemical mixture, if not the applicant; (4) The exact trade name(s) of the applicant's chemical mixture and, if the applicant formulates or manufactures the chemical mixture for other entities, the exact trade names of the chemical mixtures and the names of the entities for which the chemical mixtures were prepared; (5) The complete qualitative and quantitative composition of the chemical mixture (including all listed and non-listed chemicals) and its intended use; (6) The chemical and physical properties of the mixture and how they differ from the properties of the listed chemical or chemicals; (7) A statement which the applicant believes is justification for granting an exemption for the chemical mixture. The statement must explain how the chemical mixture meets the exemption criteria set forth in paragraph (a) of this section.
